
Browse
	Faculties & Departments
	Issue Date
	Author
	Title
	Communities & Collections

Sign on to:
	My DSpace authorized users

Search Results

Search:

for

Results 1-35 of 35.

Sort items by In order | Results/Page Authors/record

Item hits:

Issue Date	Title	Author(s)
2011	Adverse events of interferon beta-1a: a prospective multi-centre international ICH-GCP-based CRO-supported external validation study in daily practice.	Jongen, P.J.H.; Sindic, C.; Sanders, E.; Hawkins, S.; Linssen, W.; Munster, E. van; Frequin, S.T.F.M.; Borm, G.F.
2011	Drug adherence and multidisciplinary care in patients with multiple sclerosis: protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study).	Jongen, P.J.H.; Hengstman, G.J.D.; Hupperts, R.; Schrijver, H.; Gilhuis, J.; Vliegen, J.H.; Hoogervorst, E.; Huizen, M. van; Munster, E. van; Samijn, J.; Schryver, E. de; Siepman, T.; Tonk, M.; Zandbergen, E.; Holter, J. ten; Kruijk, R. van der; Borm, G.F.
2010	Chitotriosidase activity in controls and multiple sclerosis.	Verbeek, M.M.; Lefeber, D.J.; Jongen, P.J.H.
2010	Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.	Verbeek, M.M.; Notting, E.A.; Faas, B.H.W.; Claessens-Linskens, R.; Jongen, P.J.H.
2010	Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a.	Jongen, P.J.H.; Sindic, C.; Carton, H.; Zwanikken, C.P.; Lemmens, W.A.J.G.; Borm, G.F.
2009	Treatment of Voiding Dysfunction by Neuromodulation in A Selected Ms Patient Population.	Rey, F. van; Jongen, P.J.H.; Heesakkers, J.P.F.A.
2009	A Multi-Centre, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial Investigating Methylprednisolone (MP) in Combination with Interferon-b-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)	Ravnborg, M.; Soerensen, P.S.; Andersson, M.; Celius, E.G.; Jongen, P.J.H.; Batholome, E.; Elovaara, I.; Beer, K.; Constantinescu, C.
2009	Monthly cycles of methylperdnisolone in combination with interferon beta-1a IM are efficacious in the treatment of early relapsing-remitting multiple sclerosis. The MECOMBIN study.	Ravnborg, M.; Sorensen, P.; Andersson, M.; Celius, E.G.; Jongen, P.J.H.; Bartholome, E.; Elovaara, I.; Beer, K.; Constantinescu, C.
2009	Safety of long-term monthly cycles of methylprednisolone in combination with interferon beta- 1a IM in treatment -naive early relapsing-remitting multiple sclerosis patients in the MECOMBIN trial.	Ravnborg, M.; Sorensen, P.; Andersson, M.; Celius, E.G.; Jongen, P.J.H.; Batholome, E.; Elovaara, I.; Beer, K.; Sperling, B.
2009	Association between MRI parameters and the MS severity scale: a 12 year follow-up study.	Minneboo, A.; Uitdehaag, B.M.; Jongen, P.J.H.; Vrenken, H.; Knol, D.; Walderveen, M.A.A. van; Polman, C.H.; Castelijns, J.A.; Barkhof, F.
2008	The effect of memory training on the quality of life in patients with multiple sclerosis	Soe, S.T.E.; Fasotti, L.; Jongen, P.J.H.; Zwanikken, C.P.
2007	Neuromyelitis optica with clinical and histopathological involvement of the brain.	Hengstman, G.J.D.; Wesseling, P.; Frenken, C.W.; Jongen, P.J.H.
2007	Cerebrospinal fluid IgM index correlates with cranial MRI lesion load in patients with multiple sclerosis.	Jongen, P.J.H.; Lycklama-a-Nijeholt, G.J.; Lamers, K.J.B.; Doesburg, W.H.; Barkhof, F.; Lemmens, W.A.J.G.; Klasen, I.S.; Hommes, O.R.
2007	Daily negative interactions and mood among patients and partners dealing with multiple sclerosis (MS): the moderating effects of emotional support.	Kleiboer, A.M.; Kuijer, R.G.; Hox, J.J.C.M.; Jongen, P.J.H.; Frequin, S.T.F.M.; Bensing, J.M.
2006	Costs and quality of life in multiple sclerosis in The Netherlands.	Kobelt, G.; Berg, J.; Lindgren, P.; Anten, B.; Ekman, M.; Jongen, P.J.H.; Polman, C.H.; Uitdehaag, B.M.
2006	Psychiatric onset of multiple sclerosis.	Jongen, P.J.H.
2006	No effect of intravenous immunoglobulins on cytokine-producing lymphocytes in secondary progressive multiple sclerosis.	Petereit, H.F.; Reske, D.; Pukrop, R.; Maas-Enriquez, M.; Japp, G.; Jongen, P.J.H.; Kolmel, H.W.; Merkelbach, S.; Hartung, H.; Heiss, W.D.; Hommes, O.R.
2006	Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.	Kappos, L.; Traboulsee, A.; Constantinescu, C.; Eralinna, J.P.; Forrestal, F.; Jongen, P.J.H.; Pollard, J.; Sandberg-Wollheim, M.; Sindic, C.J.; Stubinski, B.; Uitdehaag, B.M.; Li, D.
2000	Abnormal neuropsychological findings are not necessarily a sign of cerebral impairment: A matched comparison between chronic fatigue syndrome and multiple sclerosis	Werf, S.P. van der; Prins, J.B.; Jongen, P.J.H.; Meer, J.W.M. van der; Bleijenberg, G.
1998	The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: Development of a model	Vercoulen, J.H.M.M.; Swanink, C.M.A.; Galama, J.M.D.; Fennis, J.F.M.; Jongen, P.J.H.; Hommes, O.R.; Meer, J.W.M. van der; Bleijenberg, G.
1997	Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis	Jongen, P.J.H.; Lamers, K.J.B.; Doesburg, W.H.; Lemmens, W.A.J.G.; Hommes, O.R.
1997	Seksuele problemen bij vrouwen met multiple sclerose	Lottman, P.E.M.; Jongen, P.J.H.; Hommes, O.R.; Rosier, P.F.W.M.; Vruggink, P.A.; Meuleman, E.J.H.
1997	Physical activity in chronic fatigue syndrome assessment and its role in fatigue	Vercoulen, J.H.M.M.; Bazelmans, E.; Swanink, C.M.A.; Fennis, J.F.M.; Galama, J.M.D.; Jongen, P.J.H.; Hommes, O.; Meer, J.W.M. van der; Bleijenberg, G.
1997	Physical activity in chronic fatigue syndrome : assessment and its role in fatigue	Vercoulen, J.H.M.M.; Bazelmans, E.; Swanink, C.M.A.; Fennis, J.F.M.; Galama, J.M.D.; Jongen, P.J.H.; Hommes, O.R.; Meer, J.W.M. van der; Bleijenberg, G.
1996	Erectiele dysfunctie bij patiënten met multiple sclerose (MS)	Lottman, P.E.M.; Rosier, P.F.W.M.; Jongen, P.J.H.; Hommes, O.R.; Meuleman, E.J.H.
1996	Comparison of two MR sequences for the detection of multiple sclerosis lesions in the spinal cord	Lycklama-a-Nijeholt, G.J.; Barkhof, F.; Castelijns, J.A.; Jongen, P.J.H.; Valk, J.; Waesberghe, J.H.T.M. van; Hommes, O.R.
1996	Automatic decomposition electromyography in idiopathic inflammatory myopathies	Jongen, P.J.H.; Vingerhoets, H.M.; Roeleveld, K.; Stegeman, D.F.
1996	The measurement of fatigue in patients with multiple sclerosis: a multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects	Vercoulen, J.H.M.M.; Hommes, O.R.; Swanink, C.M.A.; Jongen, P.J.H.; Fennis, J.F.M.; Galama, J.M.D.; Meer, J.W.M. van der; Bleijenberg, G.
1996	The measurement of fatique in patients with multiple sclerosis: a multidimensional comparison with patients with chronic fatique syndrome and healthy subjects	Vercoulen, J.H.M.M.; Hommes, O.R.; Swanink, C.M.A.; Jongen, P.J.H.; Fennis, J.F.M.; Galama, J.M.D.; Meer, J.W.M. van der; Bleijenberg, G.
1996	The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects	Vercoulen, J.H.M.M.; Hommes, O.R.; Swanink, C.M.A.; Jongen, P.J.H.; Fennis, J.F.M.; Galama, J.M.D.; Meer, J.W.M. van der; Bleijenberg, G.
1996	The clinical spectrum of limb girdle muscular dystrophy : a survey in the Netherlands	Kooi, A.J. van der; Barth, P.G.; Busch, H.F.M.; Haan, R.J. de; Ginjaar, H.B.; Essen, A.J. van; Hooff, L.J.M.A. van; Höweler, C.J.; Jennekens, F.G.I.; Jongen, P.J.H.; Oosterhuis, H.J.G.H.; Padberg, G.W.A.M.; Spaans, F.; Wintzen, A.R.; Wokke, J.H.J.; Bakker, E.; Ommen, G.J.B. van; Bolhuis, P.A.; Visser, M. de
1996	Predominant right leg dysfunction without asymmetric muscle inflammation in CD1 Swiss mice with coxsackievirus B1-induced myositis	Jongen, P.J.H.; Eling, P.; Putte, L.B.A. van de
1995	Inclusion body myositis responding to longterm chlorambucil treatment	Jongen, P.J.H.; Laak, H.J. ter; Putte, L.B.A. van de
1995	Rimmed basophilic vacuoles and filamentous inclusions in neuromuscular disorders	Jongen, P.J.H.; Laak, H.J. ter; Stadhouders, A.M.
1995	Cerebrospinal fluid free kappa light chains versus IgG findings in neurological disorders: qualitative and quantitative measurements.	Lamers, K.J.B.; Jong, J.G.N. de; Jongen, P.J.H.; Kock-Jansen, M.J.H.; Teunesen, M.A.; Prudon-Rosmulder, E.M.W.